Beyond the Numbers: The New Frontier of Diabetes Medication

31 Jul 2026 · 1 min
1:00

Dr. Jaiwant Rangi explains how diabetes drugs now need to prove they protect the heart and kidneys, not just lower blood sugar. The LEADER trial of liraglutide showed it improved heart outcomes, revealing that two patients with the same A1C level can have very different long-term results depending on which drug they take.

Chapters

More from Jaiwant

0:38
youtube.com

Unlocking the Unique Biology Behind the Six Faces of Diabetes

1mo ago
0:36
youtube.com

Unlocking the Diabetes Mystery: Why the Same Lab Results Lead to Entirely Different Realities

1mo ago
0:46
youtube.com

Decoding Diabetes: Moving Beyond Labels to Personalized Medicine

1mo ago
0:33
youtube.com

The Misdiagnosed Diabetic: Unmasking the Slow Decline of LADA

1mo ago
0:35
youtube.com

Unbraking the Body: Understanding Insulin Resistance versus Deficiency

1mo ago
0:35
youtube.com

Misdiagnosed and Mismanaged: The High Cost of Mistaking Type 1 Diabetes for Type 2

1mo ago
0:38
youtube.com

Fueling the Body: Understanding the Spectrum of Insulin Deficiency and Resistance

1mo ago
0:43
youtube.com

The Hidden Danger of Metabolic Disease in Normal-Weight Individuals

1mo ago
0:48
youtube.com

Decoding the Diagnosis: Navigating the Critical Pathways of Diabetes Reversal and Remission

1mo ago
0:46
youtube.com

Asking the Right Questions: Taking Control of Your Medical Diagnosis

1mo ago
0:36
youtube.com

The Interconnected Crisis: Why Modern Medicine Must Treat the Whole Patient

1mo ago
See all content